NEDD4L has also been found to be both upregulated and downregulated in prostate cancer, increased in invasive gallbladder cancer cells, and downregulated in more aggressive malignant gliomas [24]–[27]. This evidence concerns the gene NEDD4L and gallbladder cancer.